The Bureau
Consistent Innovation is no accident. Without a structured framework, it will never move away from a few scattered rebels driving limited impact.<br />
<br />
The Bureau starts with your business goals and helps you transform your business strategy by injecting the use of exponential technologies. <br />
<br />
We’ve adopted learnings from agile software development, and applied them to create a Continuous Innovation™ model to drive rapid, measurable outcomes for any business or technical need. <br />
<br />
We make objective progress, quickly.<br />
<br />
We're deeply experienced practitioners who have delivered tangible business results at Startup-ups through Fortune 500 – <br />
driven to ignite innovation at the heart of any organization.
The CapStreet Group
The CapStreet Group is a private equity firm based in Houston, Texas, founded in 1990. The firm focuses on investing in lower middle market companies, particularly in the software, tech-enabled services, and industrial business services sectors. CapStreet employs a team of around 19 professionals, including 4 partners, who leverage their expertise to drive growth and transformation in their portfolio companies. The firm is known for its Capvalue Framework, which helps accelerate business transformation and create long-term sustainable businesses.
CapStreet primarily invests in founder- or entrepreneur-owned businesses, with a focus on the United States. The firm has made over 50 platform investments and more than 200 add-on acquisitions since its inception. It targets companies in various stages of growth, utilizing a buy-and-build strategy to enhance value. CapStreet's investment strategy is thesis-driven, allowing them to deploy capital and resources quickly and effectively. The firm manages several funds, including CapStreet III and CapStreet IV, with assets under management totaling over $565 million.
Notable investments by CapStreet include Surgical Notes - a healthcare solutions company, Ontellus - a technology-enabled record retrieval provider, and Global Healthcare Exchange - a healthcare supply chain company. The firm has a strong track record of successful exits, including the sale of Ontellus to Datavant and Surgical Notes to Surgical Information Systems.
The Carlyle Group
The Carlyle Group is a global private equity firm based in Washington, D.C., established in 1987. With offices worldwide and over 38 years of experience, the firm operates one of the most extensive global networks in private equity, credit, and investment strategies. The team is comprised of seasoned professionals with diverse expertise, driving innovation and long-term value creation across its investments.
The firm invests in a wide array of industries including Aerospace, Automotive, Consumer Products, Energy, Financial Services, Healthcare Services, Industrial, IT Services, Media and Entertainment, and Technology, among others. With total assets under management of $475 billion, their investment sizes range significantly to cater to different types of investors and market needs.
Carlyle's portfolio includes notable companies such as United Road Services - automotive logistics provider, Supreme - streetwear brand, and Syniverse - communications platform provider. They employ a strategic approach by engaging deeply with management teams to enhance company performance and value.
The Chernin Group
Founded by Peter Chernin, Jesse Jacobs, and Mike Kerns, The Chernin Group (TCG) is a preeminent growth equity firm investing in sports, media, and passion-driven businesses with offices in Los Angeles, Menlo Park, and New York. The TCG portfolio includes Collectors, Classic Football Shirts, Epic Gardening, Food52, Headspace, Meateater, Oura, Surfline, Unrivaled Sports and more.
We partner with exceptional founders and management teams who have created disruptive brands to grow and optimize their businesses. With decades of operational expertise and strong connections across media, sports, and technology, we work every day to help our portfolio companies realize their full potential.
At TCG, we follow our curiosity, live with conviction, and find a little levity in our days. We don’t take small bets – we’re all in.
To learn more, visit: https://tcg.co/
The Column Group
The Column Group (TCG) is a venture capital firm based in San Francisco, California, founded in 2007 by Peter Svennilson. The firm focuses on early-stage investments in the life sciences sector, particularly in biotechnology and drug discovery. TCG is known for its unique approach to venture capital, emphasizing long-term investments and company formation rather than quick exits. The team comprises 23 professionals, including partners with deep scientific and financial expertise.
TCG invests primarily in the United States, targeting sectors such as healthcare, life sciences, oncology, and technology-based industries. The firm operates an ecosystem of funds, including TCG Platform funds, TCG Opportunity funds, and TCG Labs-Soleil, which support technology platforms and later-stage programs. TCG has generated $4 billion in returns for its partners and manages several funds, including The Column Group IV and The Column Group Opportunity III.
Notable portfolio companies include Carmot Therapeutics - drug discovery, Peloton Therapeutics - oncology, Aragon Pharmaceuticals - prostate cancer treatments, Neurona Therapeutics - cell therapy, and Constellation Pharmaceuticals - epigenetics. TCG's investments have led to 18 successful exits, showcasing its impact on the biotech industry.
The Community Fund
We are operators, founders, and investors that bring a wide range of complementary functional and industry expertise.
The Community Fund led by Lolita Taub and Jesse Middleton is a $5 million early-stage fund that invests in community-driven companies through an investment partner team. We believe that companies with community at the center of all that they do will become unicorns and produce outsized returns.
The investment team includes: Elias Torres, Cheryl Campos, Calanthia Mei, Melissa Moore, Hassan Bhatti, Sonia Nagar, Aaron Samuels, Kara Weber, Mike Swift, Songe LaRon, and Dave Salvant.
The Cove Fund
The Cove Fund is a venture capital firm based in Irvine, California, specifically located at 'The Cove' at UC Irvine Beall Applied Innovation. Founded to leverage the Southern California startup ecosystem, the firm works closely with the area's entrepreneurs, universities, and investors. The team includes experienced fund managers and a network of Members—investors who contribute their expertise, experience, and networks. The fund prides itself on its rigorous investment process and partnership-centric approach with portfolio companies.
The Cove Fund primarily invests in seed-stage technology and life science companies, focusing on those within Southern California and affiliated with the University of California system. They employ a 'seed and feed' strategy, typically making initial investments ranging from $250K to $1M. The firm participates in seed rounds in the $1-5M range, aiming for rapid scalability and significant value creation before the next funding stages. Their target horizon for exits is 5-7 years with a significant return on investment.
Notable investments by the Cove Fund include various companies across the tech and life sciences sectors, although specific names of portfolio companies were not provided. The firm emphasizes a unique value in supporting their portfolio companies through governance assistance, mentoring, and leveraging their Members' networks to foster company growth.
The Craftory
The Craftory is a venture capital investor based in London and San Francisco, established to invest in category-transforming consumer brands. Founded by industry veterans, The Craftory manages a portfolio valued at $550 million, providing capital to companies that are responsible and positively impacting society and the planet. With a team comprising deep industry experts, they offer networking, mentoring, and guidance in sustainability and product innovation.
Focusing on consumer packaged goods, The Craftory targets investments during Series A, B, and C rounds. They prioritize sectors including beauty and personal care, health and wellness, food and beverages, and household products. The Craftory is known for its patient growth capital approach, aiming to set a new standard for responsible consumption.
Notable investments by The Craftory include NotCo - plant-based food products, Dropps - eco-friendly household products, Hippeas - organic chickpea snacks, Edgard & Cooper - pet food, and TomboyX - gender-neutral clothing. They are committed to supporting brands that demonstrate tangible societal benefits and environmental responsibility.
The Cranemere Group Ltd.
The Cranemere Group Ltd. is a private investment company based in London and New York. The firm takes a long-term approach to investing, providing permanent capital to its portfolio companies. Cranemere was founded with the purpose of partnering with founders, family-owned businesses, and management teams, focusing on building enduring companies over decades. The team is composed of experienced professionals who work closely with companies to drive sustainable growth and innovation.
Cranemere invests across the services, industrial, and consumer sectors. The firm's unique structure allows for a perpetual capital model, which supports capital investments and acquisitions to facilitate growth and lasting value creation. Cranemere's flexible, patient capital strategy enables it to partner with companies at various stages, with no specific constraints on check size. The firm emphasizes a values-aligned partnership model, resulting in a strong alignment with its investees.
Notable investments by The Cranemere Group include Exemplis - office furniture, ES Group - surfaces manufacturing, NorthStar Anesthesia - healthcare services, Velocity Vehicle Group - commercial vehicles, and Crossroads Lease & Finance - financial services. These companies illustrate Cranemere's focus on building influential businesses across diverse industries.
The Cryptos Fund
The Cryptos Fund invests primarily in blockchain and cryptocurrency-related ventures. Despite not having full access to their website, the fund is presumably based on investing in digital assets and supporting startups involved in the decentralized economy. The exact headquarters and founding year are unknown due to the lack of access. Details about their team composition, including the founders or prominent partners, are also unavailable, which limits insights into what distinguishes them from other funds in the cryptocurrency investment space.
Details regarding the specific investment strategy of The Cryptos Fund, such as sector focus beyond blockchain and crypto, check sizes, stages, and geographical reach, are speculative without direct signals. Additionally, their total assets under management and any specific fund series are not disclosed, given the current information limitations.
Existing notable investments are not publicly detailed, so potential portfolio companies remain unidentified. The general approach to investment can range broadly within the cryptocurrency ecosystem, influencing various aspects of blockchain technology, decentralized finance, and digital assets.